Telecom Healthcare Sector

Xylo Technologies

Market Cap: US$6.7m

A technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally.

GT Biopharma

Market Cap: US$6.7m

A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.

Glow Lifetech

Market Cap: CA$9.4m

A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products.

Genprex

Market Cap: US$6.7m

A clinical-stage gene therapy company, focuses on developing gene-based therapies for patient populations with unmet medical needs.

Theracryf

Market Cap: UK£5.0m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders.

Khiron Life Sciences

Market Cap: CA$9.3m

Operates as an integrated medical and cannabis company in Latin America and Europe.

Universal Ibogaine

Market Cap: CA$9.3m

A life sciences company, develops, acquires, and operates addiction treatment clinics in Canada.

CNS Pharmaceuticals

Market Cap: US$6.7m

A clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors.

National Graphite

Market Cap: US$6.6m

Through its subsidiary, Biotech Development Corp., operates as a biopharmaceutical risk/cost-sharing company.

Avant Brands

Market Cap: CA$9.2m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

TransCode Therapeutics

Market Cap: US$6.6m

A biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer.

Kane Biotech

Market Cap: CA$9.2m

A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.

Ontrak

Market Cap: US$6.6m

Operates as a value-based behavioral healthcare company in the United States.

Cannabis Bioscience International Holdings

Market Cap: US$6.6m

Cannabis Bioscience International Holdings, Inc.

Therma Bright

Market Cap: CA$9.1m

Acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace.

Innovative Eyewear

Market Cap: US$6.5m

Engages in the development and sale of smart eyeglasses and sunglasses in North America.

Beyond Medical Technologies

Market Cap: US$6.5m

Does not have significant operations.

Algorae Pharmaceuticals

Market Cap: AU$10.1m

A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.

Telo Genomics

Market Cap: CA$9.0m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.

Aptorum Group

Market Cap: US$6.4m

Through its subsidiaries, operates as a clinical stage biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutic products for the treatment of oncology and infectious diseases.

Univec

Market Cap: US$6.4m

Provides health care services in the United States.

Nymox Pharmaceutical

Market Cap: US$6.4m

A biopharmaceutical company, engages in the research and development of products for the aging population in Canada, the United States, and Europe.

AIM ImmunoTech

Market Cap: US$6.4m

An immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.

Memphasys

Market Cap: AU$9.9m

Develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.

Mountain Valley MD Holdings

Market Cap: CA$8.8m

Through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company in Canada.

Lyra Therapeutics

Market Cap: US$6.2m

A clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis.

Incannex Healthcare

Market Cap: US$6.2m

A clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia.

Enzon Pharmaceuticals

Market Cap: US$6.2m

Does not have significant operations.

ProText Mobility

Market Cap: US$6.2m

A biotech company, engages in the development of pharmaceutical botanical medicines.

Soligenix

Market Cap: US$6.1m

A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.

Indaptus Therapeutics

Market Cap: US$6.1m

A clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products.

Traws Pharma

Market Cap: US$6.1m

A clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer.

Control Bionics

Market Cap: AU$9.4m

Engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally.

Channel Therapeutics

Market Cap: US$6.0m

A clinical-stage biotech company, develops and commercializes new therapeutics to alleviate pain.

Sentient Brands Holdings

Market Cap: US$6.0m

A product development and brand management company, builds brands in the luxury and premium market space.

Acrux

Market Cap: AU$9.4m

Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.